scorpion wrote:Cece I really think CCSVI will start seeing some of that money when and if some of the current trials start showing a link between MS and CCSVI.
Here is the major problem as I see it. The link between MS and CCSVI is irrelevant! If the current studies that at funded by the MS Society show no connection then research will not continue to be funded.
What if the studies found that CCSVI is less prevalent in the MS population? How would that change the fact that improving blood flow with angioplasty improves the lives of MS sufferers? There are thousands of people of who would vouch for the fact that none of the drugs that they take have provided near the relief that angioplasty did.
We need research on the treatment, not on the statistical prevalanse of CCSVI, as interesting as it is.
(and no, I don’t have scientific proof of the thousands of people)